UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000044649
Receipt No. R000050995
Scientific Title Multicenter prospective observational study on metastatic hormone-naive prostate cancer
Date of disclosure of the study information 2021/06/24
Last modified on 2021/06/24 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Multicenter prospective observational study on metastatic hormone-naive prostate cancer
Acronym Multicenter prospective observational study on metastatic hormone-naive prostate cancer
Scientific Title Multicenter prospective observational study on metastatic hormone-naive prostate cancer
Scientific Title:Acronym Multicenter prospective observational study on metastatic hormone-naive prostate cancer
Region
Japan

Condition
Condition metastatic hormone-naive prostate cancer
Classification by specialty
Urology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate the clinical outcomes of metastatic hormone-naive prostate cancer in Japan
Basic objectives2 Others
Basic objectives -Others To evaluate the clinical practice of metastatic hormone-naive prostate cancer in Japan
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Clinical practice and outcomes of metastatic hormone-naive prostate cancer
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male
Key inclusion criteria Metastatic hormone naive prostate cancer
Key exclusion criteria Patients for whom it is impossible to obtain consent
Target sample size 400

Research contact person
Name of lead principal investigator
1st name Yasuhisa
Middle name
Last name Fujii
Organization Tokyo Medical and Dental University
Division name Urology
Zip code 113-8519
Address 1-5-45 Yushima, Bunkyo-ku, Tokyo
TEL 03-5803-5295
Email ikyouro@tmd.ac.jp

Public contact
Name of contact person
1st name Soichiro
Middle name
Last name Yoshida
Organization Tokyo Medical and Dental University
Division name Urology
Zip code Tokyo Medical and Dental University
Address 1-5-45 Yushima, Bunkyo-ku, Tokyo
TEL 03-5803-5295
Homepage URL
Email ikyouro@tmd.ac.jp

Sponsor
Institute Tokyo Medical and Dental University
Institute
Department

Funding Source
Organization Tokyo Medical and Dental University
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Tokyo Medical and Dental University
Address 1-5-45 Yushima, Bunkyo-ku, Tokyo
Tel 03-5803-5295
Email ikyouro@tmd.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 06 Month 24 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2021 Year 04 Month 21 Day
Date of IRB
2021 Year 04 Month 28 Day
Anticipated trial start date
2021 Year 04 Month 28 Day
Last follow-up date
2026 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Prospective registration of clinical and pathological information obtained from medical records

Management information
Registered date
2021 Year 06 Month 24 Day
Last modified on
2021 Year 06 Month 24 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050995